| Literature DB >> 33315190 |
Per Andrén1,2, Vera Wachtmeister3, Julia Franzé4, Caroline Speiner4, Lorena Fernández de la Cruz5,3, Erik Andersson5,3,4, Elles de Schipper5,3, Daniel Rautio5,3, Maria Silverberg-Mörse3, Eva Serlachius5,3, David Mataix-Cols5,3.
Abstract
It is unclear if the results of randomised controlled trials (RCTs) of behaviour therapy (BT) for Tourette syndrome (TS) and chronic tic disorder (CTD) can be generalised to naturalistic clinical settings and are durable long-term. In this naturalistic study, 74 young people with TS/CTD received BT at a specialist clinic. Data were collected at baseline, post-treatment, and at 3-, 6-, and 12-month follow-ups. Measures included the Yale Global Tic Severity Scale (YGTSS) and the Clinical Global Impression-Improvement scale (CGI-I), amongst others. Tic severity and tic-related impairment improved after treatment, with large within-group effect sizes. At post-treatment, 57% of the participants were classified as treatment responders according to the CGI-I. Tic severity and tic-related impairment improved further through the follow-up, with 75% treatment responders at the 12-month follow-up. BT is an effective and durable treatment for young people with TS/CTD in a naturalistic specialist clinical setting, with comparable effects to RCTs.Entities:
Keywords: Behaviour therapy; Exposure with response prevention; Habit reversal training; Tic disorders; Tourette syndrome
Year: 2020 PMID: 33315190 DOI: 10.1007/s10578-020-01098-y
Source DB: PubMed Journal: Child Psychiatry Hum Dev ISSN: 0009-398X